z-logo
open-access-imgOpen Access
Update to “Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors”
Author(s) -
Mojun Zhu,
Tanios BekaiiSaab
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac068
Subject(s) - radionuclide therapy , peptide receptor , medicine , neuroendocrine tumors , cancer research , oncology , receptor , homologous recombination , genetics , dna , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom